This grant from the National Institute of Allergy and Infectious Diseases aims to support the rapid implementation of early clinical trials using monoclonal antibodies (mAbs) for achieving drug-free sustained virologic remission in HIV-infected individuals. Applications are sought for testing native and/or engineered mAbs for this purpose. Deadline for submission is October 9, 2019.
Opportunity ID: 306655
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-18-022 |
| Funding Opportunity Title: | Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 28, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 09, 2019 |
| Current Closing Date for Applications: | Oct 09, 2019 |
| Archive Date: | Nov 14, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Small businesses City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Special district governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal governments (Federally recognized) Independent school districts State governments Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The Purpose of this Funding Opportunity Announcement is to solicit applications to rapidly implement early clinical trials using native and/or engineered monoclonal antibodies (mAbs) to achieve a drug-free sustained virologic remission in HIV infected individuals. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-18-022.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | FORMS-E | PKG00243459 | Sep 10, 2018 | Oct 09, 2019 | View |
Package 1
Mandatory forms
306655 RR_SF424_2_0-2.0.pdf
306655 PHS398_CoverPageSupplement_4_0-4.0.pdf
306655 RR_OtherProjectInfo_1_4-1.4.pdf
306655 PerformanceSite_2_0-2.0.pdf
306655 RR_KeyPersonExpanded_2_0-2.0.pdf
306655 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
306655 RR_Budget_1_4-1.4.pdf
306655 RR_SubawardBudget30_1_4-1.4.pdf
306655 PHS398_ModularBudget_1_2-1.2.pdf
306655 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
